Neogen Corporation

Neogen Corporation Earnings Recaps

NEOG Health Care 1 recap
Q4 2025 Aug 2, 2025

Neogen Corporation's fourth quarter results reflect ongoing challenges in the Food Safety segment, compounded by market and regulatory pressures. However, strategic initiatives in pathogen detection and operational simplification signal a focused path forward.

Key takeaways
  • Food Safety end market conditions worsened due to ongoing inflation pressures, leading to lower production volumes among food producers.
  • Neogen launched the Listeria Right Now assay on its MDS platform, enhancing pathogen detection capabilities.
  • The Board is transitioning the CEO role to better align with future growth potential amidst a regulatory environment prioritizing food safety.
  • Core revenue in the Animal Safety segment has faced headwinds, but signs of improvement in net farm incomes could support recovery.
  • Ongoing divestiture processes aim to streamline operations and prioritize core business areas for improved focus and deleveraging.